NATERA, INC. Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers Into Level 3
NATERA, INC. (NTRA) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers Into Level 3 of $0 for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-02.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation › Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3 · last filed 2020-03-02
- NATERA, INC. fair value, measurement with unobservable inputs reconciliation, liability, transfers into level 3 for fiscal 2019 was $0.00.
- NATERA, INC. fair value, measurement with unobservable inputs reconciliation, liability, transfers into level 3 for fiscal 2018 was $0.00.
- NATERA, INC. fair value, measurement with unobservable inputs reconciliation, liability, transfers into level 3 for fiscal 2017 was $0.00.
- NATERA, INC. fair value, measurement with unobservable inputs reconciliation, liability, transfers into level 3 for fiscal 2016 was $0.00.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers Into Level 3 12 month |
|---|---|
| 2019-12-31 | $0.00 10-K · filed 2020-03-02 |
| 2018-12-31 | $0.00 10-K · filed 2020-03-02 |
| 2017-12-31 | $0.00 10-K · filed 2019-03-15 |
| 2016-12-31 | $0.00 10-K · filed 2018-03-15 |
| 2015-12-31 | $0.00 10-K · filed 2017-03-16 |
| 2014-12-31 | $0.00 10-K · filed 2016-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |